Literature DB >> 10961332

Enantioseparations in non-aqueous capillary electrochromatography using polysaccharide type chiral stationary phases.

M Girod1, B Chankvetadze, G Blaschke.   

Abstract

Enantioseparations of chiral compounds with different structures were studied in non-aqueous capillary electrochromatography (NAQ CEC). Three different polysaccharide derivatives, cellulose tris(3,5-dimethylphenylcarbamate) (Chiralcel OD), amylose tris(3,5-dimethylphenylcarbamate) (Chiralpak AD) and cellulose tris(4-methylbenzoate) (Chiralcel OJ) were used as chiral stationary phases (CSPs). Methanolic or ethanolic ammonium acetate solutions served as a mobile phase. The effect of the type of the CSP, the loading of the chiral selector on wide-pore aminopropyl derivatized silica gel and operational parameters such as apparent pH, applied voltage, etc. on the EOF and chromatographic characteristics (alpha, N, Rs) were studied. NAQ CEC represents a valuable alternative and an extension to chiral separations by HPLC with common-size columns as well as to capillary LC and CEC in aqueous buffers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961332     DOI: 10.1016/s0021-9673(99)01204-2

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  3 in total

Review 1.  Chiral separation principles in chromatographic and electromigration techniques.

Authors:  Gerald Gübitz; Martin G Schmid
Journal:  Mol Biotechnol       Date:  2006-02       Impact factor: 2.695

2.  Chiral separation of indapamide enantiomers by capillary electrophoresis.

Authors:  Amelia Tero-Vescan; Gabriel Hancu; Mihaela Oroian; Anca Cârje
Journal:  Adv Pharm Bull       Date:  2014-02-07

3.  Sulfated and sulfonated polysaccharide as chiral stationary phases for capillary electrochromatography and capillary electrochromatography-mass spectrometry.

Authors:  Jie Zheng; William Bragg; Jingguo Hou; Na Lin; Sekar Chandrasekaran; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2008-12-06       Impact factor: 4.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.